Literature DB >> 23400636

Patient with homer-3 antibodies and cerebellitis.

Romana Höftberger1, Lidia Sabater, Angel Ortega, Josep Dalmau, Francesc Graus.   

Abstract

IMPORTANCE: Homer proteins are a family of scaffolding proteins of the postsynaptic density. Homer-3 colocalizes and modulates the activity of group I metabotropic glutamate receptors (mGluR1 and mGluR5). Cerebellitis has been reported in association with antibodies to mGluR1. We describe the second patient with cerebellitis and Homer-3 antibodies and report a novel, highly specific immunoblot assay. OBSERVATIONS: A 38-year-old man had acute onset of headache, nausea, vomiting, and confusion. He developed a pancerebellar syndrome during the ensuing week. Extensive studies did not reveal any tumor. Cerebrospinal fluid analysis showed a white blood cell count of 60/μL (to convert to ×109 per liter, multiply by 0.001). Brain magnetic resonance imaging findings were normal. For 2 years, the patient was treated with intravenous immunoglobulins and steroids, with partial improvement of the cerebellar ataxia. The patient was negative for onconeural (Hu, Yo, Ri, CV2, Tr, amphiphysin, and Ma2), glutamic acid decarboxylase, and mGluR1 antibodies. Immunohistochemistry on rat brain revealed immunostaining of the cerebellar molecular layer. Homer-3 antibodies were demonstrated by immunoblot of recombinant Homer-3. The clinical features of this patient and a previously described patient with Homer-3 antibodies are similar to those of patients with mGluR1 antibodies. CONCLUSIONS AND RELEVANCE: We report the second case of autoimmune cerebellar ataxia associated with Homer-3 antibodies. The presence of Homer-3 autoantibodies should be considered in the differential diagnosis of patients with subacute cerebellar ataxia of unknown cause.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23400636      PMCID: PMC3723144          DOI: 10.1001/jamaneurol.2013.1955

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  11 in total

1.  Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor.

Authors:  P Sillevis Smitt; A Kinoshita; B De Leeuw; W Moll; M Coesmans; D Jaarsma; S Henzen-Logmans; C Vecht; C De Zeeuw; N Sekiyama; S Nakanishi; R Shigemoto
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

2.  Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease?

Authors:  Romain Marignier; Florian Chenevier; Veronique Rogemond; Peter Sillevis Smitt; Christel Renoux; Gaëlle Cavillon; Geraldine Androdias; Sandra Vukusic; Francesc Graus; Jérôme Honnorat; Christian Confavreux
Journal:  Arch Neurol       Date:  2010-05

3.  Homer 3 autoimmunity in subacute idiopathic cerebellar ataxia.

Authors:  L Zuliani; L Sabater; A Saiz; J J Baiges; B Giometto; F Graus
Journal:  Neurology       Date:  2007-01-16       Impact factor: 9.910

4.  Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome.

Authors:  E Lancaster; E Martinez-Hernandez; M J Titulaer; M Boulos; S Weaver; J-C Antoine; E Liebers; C Kornblum; C G Bien; J Honnorat; S Wong; J Xu; A Contractor; R Balice-Gordon; J Dalmau
Journal:  Neurology       Date:  2011-10-19       Impact factor: 9.910

5.  Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.

Authors:  J Honnorat; A Saiz; B Giometto; A Vincent; L Brieva; C de Andres; J Maestre; N Fabien; A Vighetto; R Casamitjana; C Thivolet; B Tavolato; J Antoine; P Trouillas; F Graus
Journal:  Arch Neurol       Date:  2001-02

6.  Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodies.

Authors:  Michiel Coesmans; Peter A Sillevis Smitt; David J Linden; Ryuichi Shigemoto; Tomoo Hirano; Yoshinori Yamakawa; Adriaan M van Alphen; Chongde Luo; Josef N van der Geest; Johan M Kros; Carlo A Gaillard; Maarten A Frens; Chris I de Zeeuw
Journal:  Ann Neurol       Date:  2003-03       Impact factor: 10.422

7.  Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.

Authors:  Albert Saiz; Yolanda Blanco; Lidia Sabater; Félix González; Luis Bataller; Roser Casamitjana; Lluis Ramió-Torrentà; Francesc Graus
Journal:  Brain       Date:  2008-08-07       Impact factor: 13.501

8.  Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.

Authors:  Setareh Shams'ili; Joost Grefkens; Bertie de Leeuw; Martin van den Bent; Herbert Hooijkaas; Bronno van der Holt; Charles Vecht; Peter Sillevis Smitt
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

9.  Cerebellar encephalitis in adults.

Authors:  T Klockgether; G Döller; U Wüllner; D Petersen; J Dichgans
Journal:  J Neurol       Date:  1993-01       Impact factor: 4.849

10.  Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.

Authors:  Esther B E Becker; Luigi Zuliani; Rosemary Pettingill; Bethan Lang; Patrick Waters; Anna Dulneva; Frank Sobott; Mark Wardle; Francesc Graus; Luis Bataller; Neil P Robertson; Angela Vincent
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-02-15       Impact factor: 10.154

View more
  18 in total

Review 1.  Paraneoplastic disorders.

Authors:  Eric Lancaster
Journal:  Continuum (Minneap Minn)       Date:  2015-04

Review 2.  Neuronal central nervous system syndromes probably mediated by autoantibodies.

Authors:  Aude Chefdeville; Jérôme Honnorat; Christiane S Hampe; Virginie Desestret
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

3.  Magnetic resonance imaging findings in patients presenting with (sub)acute cerebellar ataxia.

Authors:  Tanja Schneider; Götz Thomalla; Einar Goebell; Anna Piotrowski; David Mark Yousem
Journal:  Neuroradiology       Date:  2015-02-17       Impact factor: 2.804

4.  Encephalitis patient-derived monoclonal GABAA receptor antibodies cause epileptic seizures.

Authors:  Jakob Kreye; Sukhvir K Wright; Adriana van Casteren; Laura Stöffler; Marie-Luise Machule; S Momsen Reincke; Marc Nikolaus; Scott van Hoof; Elisa Sanchez-Sendin; Marie A Homeyer; César Cordero Gómez; Hans-Christian Kornau; Dietmar Schmitz; Angela M Kaindl; Philipp Boehm-Sturm; Susanne Mueller; Max A Wilson; Manoj A Upadhya; Divya R Dhangar; Stuart Greenhill; Gavin Woodhall; Paul Turko; Imre Vida; Craig C Garner; Jonathan Wickel; Christian Geis; Yuko Fukata; Masaki Fukata; Harald Prüss
Journal:  J Exp Med       Date:  2021-09-21       Impact factor: 14.307

5.  Clinical Features and Neuroimaging Findings of Neuropil Antibody-Positive Idiopathic Sporadic Ataxia of Unknown Etiology.

Authors:  Akira Takekoshi; Akio Kimura; Nobuaki Yoshikura; Isamu Yamakawa; Makoto Urushitani; Katsuya Nakamura; Kunihiro Yoshida; Takayoshi Shimohata
Journal:  Cerebellum       Date:  2022-09-03       Impact factor: 3.648

6.  Anti-homer-3 Antibody Encephalitis in a 10-Year-Old Child: Case Report and Review of the Literature.

Authors:  Zuying Kuang; José Fidel Baizabal-Carvallo; Mohammad Mofatteh; Sifen Xie; Zhanhang Wang; Yimin Chen
Journal:  Front Neurol       Date:  2022-06-13       Impact factor: 4.086

Review 7.  Novelties in Autoimmune and Paraneoplastic Cerebellar Ataxias: Twenty Years of Progresses.

Authors:  Sergio Muñiz-Castrillo; Alberto Vogrig; Nicolás Lundahl Ciano-Petersen; Macarena Villagrán-García; Bastien Joubert; Jérôme Honnorat
Journal:  Cerebellum       Date:  2022-01-12       Impact factor: 3.648

Review 8.  Are Type 1 metabotropic glutamate receptors a viable therapeutic target for the treatment of cerebellar ataxia?

Authors:  Emmet M Power; Natalya A English; Ruth M Empson
Journal:  J Physiol       Date:  2016-02-24       Impact factor: 5.182

Review 9.  'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

10.  Ionotropic Receptors as a Driving Force behind Human Synapse Establishment.

Authors:  Lucas Henriques Viscardi; Danilo Oliveira Imparato; Maria Cátira Bortolini; Rodrigo Juliani Siqueira Dalmolin
Journal:  Mol Biol Evol       Date:  2021-03-09       Impact factor: 16.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.